Navigation Links
ABR-Affinity BioReagents Inks New Distribution Agreements in Switzerland and Hungary
Date:5/9/2008

DENVER and GOLDEN, Colo., May 9 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the finalization of new distribution agreements with LuBioScience GmbH, headquartered in Lucerne, Switzerland and Bio-Kasztel Ltd., located in Budapest, Hungary, further expanding its already extensive network of distribution partners in Europe.

LubioScience has more than 30 years of expertise in handling marketing and sales of life science reagents in Switzerland and distributes a broad range of life science reagents for experimental use in laboratories. Similarly, Bio-Kasztel has long-term marketing and distribution experience and close ties with all of the top-level academic and research institutions in Hungary. According to Ken Wilczek, President of ABR-Affinity BioReagents, "Partnering with companies like LuBioScience and Bio-Kasztel enhances our presence in the growing European life science community, and we have a history of working closely with high caliber distribution partners such as these to really penetrate deep into foreign markets. These types of international distribution arrangements allow us the ability and flexibility to offer our quality guaranteed experimental research tools to foreign-based scientists who are active in the worldwide effort to combat disease and enhance the quality of life for everyone." With the recent launch of over 1,600 new products in the areas of Neuroscience, Cancer Biology, Immunology, Inflammation and Arthritis, Diabetes and Vision Research, ABR-Affinity BioReagents' portfolio of high quality antibodies continues to grow in breadth and depth of research reagents available worldwide.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, and custom antibody and peptide production services, known as Antibody on Demand.

With more than 36,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 60 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-- - -Affinity BioReagents, contact

Leslie Martin with ABR media relations at 1-800-527-4535.


'/>"/>
SOURCE ABR-Affinity BioReagents
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas
2. ABR-Affinity BioReagents Announces Its Continued Support for the Society for Neuroscience Annual Meeting in San Diego, November 3 - 7, 2007
3. ABR-Affinity BioReagents Expands 100% Quality Guarantee
4. ABR -- Affinity BioReagents Announces Launch of New Website
5. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
6. AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line
7. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
8. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
9. Zipfizz(R) Announces Distribution Deal With the Odom Corporation
10. Cardinal Health, ClearCount Medical Solutions Sign Primary Distribution Agreement for RFID-Enabled Sponge Counting, Detection System
11. Bally Total Fitness Announces Interim Chapter 11 Plan Distribution to Former Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... Lawn, NJ (PRWEB) , ... February 23, 2017 ... ... specializing in thought leadership , media relations, content marketing, social media management, ... With several clients already in the state and in nearby New Hampshire, Massachusetts ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... interactive publication where generations converge and explore the world from different perspectives. By ... Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 AcelRx ... focused on the development and commercialization of innovative ... announced that it will release fourth quarter and ... March 2nd, 2017. AcelRx management will host an ... (1:30 p.m. Pacific Time) on March 2 nd ...
(Date:2/23/2017)... COTTAGE, New York , February 23, 2017 /PRNewswire/ ... health implications arising from increasing caseload for varicose veins ... recorded across the globe are prompting the adoption of ... latest study on global endovenous laser therapy ... attention towards aftereffects of lifestyle choices and consequences of ...
(Date:2/23/2017)... Research and Markets has announced the addition ... Forecast to 2025" report to their offering. ... The Global Endoscopy Market is ... next decade to reach approximately $47.6 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology: